Delaware
|
13-4996950
|
(State
or other jurisdiction
|
(I.R.S.
Employer Identification No.)
|
of
incorporation or organization)
|
469
North Harrison Street, Princeton, N.J. 08543-5297
|
(Address
of principal executive office)
|
Large accelerated filer | x | Accelerated filer | o | ||
Non-accelerated filer | o | Smaller reporting company | o |
Item
|
Page
|
|
1.
|
3
|
|
2.
|
21
|
|
3.
|
26
|
|
4.
|
27
|
1.
|
28
|
|
1A.
|
28
|
|
4.
|
28
|
|
6.
|
29
|
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(Dollars
in thousands, except per share data)
|
2009
|
2008
|
||||||
Net
Sales
|
$ | 580,867 | $ | 552,867 | ||||
Cost
of sales
|
331,509 | 328,761 | ||||||
Gross
Profit
|
249,358 | 224,106 | ||||||
Marketing
expenses
|
66,373 | 53,485 | ||||||
Selling,
general and administrative expenses
|
78,325 | 77,859 | ||||||
Income
from Operations
|
104,660 | 92,762 | ||||||
Equity
in earnings of affiliates
|
2,705 | 2,380 | ||||||
Investment
earnings
|
392 | 2,569 | ||||||
Other
income (expense), net
|
484 | 2,198 | ||||||
Interest
expense
|
(8,749 | ) | (12,505 | ) | ||||
Income
before Income Taxes
|
99,492 | 87,404 | ||||||
Income
taxes
|
36,916 | 31,211 | ||||||
Net
Income
|
62,576 | 56,193 | ||||||
Noncontrolling
interest
|
7 | 2 | ||||||
Net
Income attributable to Church & Dwight Co., Inc.
|
$ | 62,569 | $ | 56,191 | ||||
Weighted
average shares outstanding - Basic
|
70,234 | 66,343 | ||||||
Weighted
average shares outstanding - Diluted
|
71,312 | 70,817 | ||||||
Net
income per share - Basic
|
$ | 0.89 | $ | 0.85 | ||||
Net
income per share - Diluted
|
$ | 0.88 | $ | 0.81 | ||||
Cash
dividends per share
|
$ | 0.09 | $ | 0.08 |
March
27,
|
December
31,
|
|||||||
(Dollars
in thousands, except per share data)
|
2009
|
2008
|
||||||
Assets
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 280,241 | $ | 197,999 | ||||
Accounts
receivable, less allowances of $5,567 and $5,427
|
216,469 | 211,194 | ||||||
Inventories
|
199,882 | 198,893 | ||||||
Deferred
income taxes
|
17,114 | 15,107 | ||||||
Prepaid
expenses
|
11,648 | 10,234 | ||||||
Other
current assets
|
31,476 | 31,694 | ||||||
Total
Current Assets
|
756,830 | 665,121 | ||||||
Property,
Plant and Equipment, Net
|
398,965 | 384,519 | ||||||
Equity
Investment in Affiliates
|
9,821 | 10,061 | ||||||
Tradenames
and Other Intangibles
|
803,907 | 810,173 | ||||||
Goodwill
|
845,412 | 845,230 | ||||||
Other
Assets
|
85,681 | 86,334 | ||||||
Total
Assets
|
$ | 2,900,616 | $ | 2,801,438 | ||||
Liabilities
and Stockholders' Equity
|
||||||||
Current
Liabilities
|
||||||||
Short-term
borrowings
|
$ | 35,268 | $ | 3,248 | ||||
Accounts
payable and accrued expenses
|
307,804 | 310,622 | ||||||
Current
portion of long-term debt
|
95,631 | 71,491 | ||||||
Income
taxes payable
|
20,906 | 1,760 | ||||||
Total
Current Liabilities
|
459,609 | 387,121 | ||||||
Long-term
Debt
|
740,282 | 781,402 | ||||||
Deferred
Income Taxes
|
183,802 | 171,981 | ||||||
Deferred
and Other Long Term Liabilities
|
93,613 | 93,430 | ||||||
Pension,
Postretirement and Postemployment Benefits
|
32,833 | 35,799 | ||||||
Total
Liabilities
|
1,510,139 | 1,469,733 | ||||||
Commitments
and Contingencies
|
||||||||
Stockholders'
Equity
|
||||||||
Preferred
Stock-$1.00 par value
|
||||||||
Authorized
2,500,000 shares, none issued
|
- | - | ||||||
Common
Stock-$1.00 par value
|
||||||||
Authorized
300,000,000 shares, issued 73,213,775 shares
|
73,214 | 73,214 | ||||||
Additional
paid-in capital
|
257,064 | 252,129 | ||||||
Retained
earnings
|
1,120,188 | 1,063,928 | ||||||
Accumulated
other comprehensive loss
|
(24,017 | ) | (20,454 | ) | ||||
Common
stock in treasury, at cost:
|
||||||||
3,025,682 shares in 2009 and 3,140,931 shares in
2008
|
(36,168 | ) | (37,304 | ) | ||||
Total
Church & Dwight Co., Inc. Stockholders' Equity
|
1,390,281 | 1,331,513 | ||||||
Noncontrolling
interest
|
196 | 192 | ||||||
Total
Stockholders' Equity
|
1,390,477 | 1,331,705 | ||||||
Total
Liabilities and Stockholders’ Equity
|
$ | 2,900,616 | $ | 2,801,438 |
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(Dollars
in thousands)
|
2009
|
2008
|
||||||
Cash
Flow From Operating Activities
|
||||||||
Net
Income
|
$ | 62,569 | $ | 56,191 | ||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||
Depreciation and amortization
|
21,670 | 15,212 | ||||||
Equity in earnings of affiliates
|
(2,705 | ) | (2,380 | ) | ||||
Distributions from unconsolidated affiliates
|
2,945 | 2,564 | ||||||
Deferred income taxes
|
10,106 | 2,103 | ||||||
Asset impairment charges and other asset write-offs
|
- | 5,626 | ||||||
Gain on sale of assets
|
- | (3,005 | ) | |||||
Non cash compensation expense
|
2,707 | 2,424 | ||||||
Unrealized foreign exchange gain and other
|
(379 | ) | (2,558 | ) | ||||
Change
in assets and liabilities:
|
||||||||
Accounts receivable
|
(7,980 | ) | 3,436 | |||||
Inventories
|
(2,348 | ) | (3,549 | ) | ||||
Prepaid expenses
|
(1,466 | ) | (2,409 | ) | ||||
Accounts payable and accrued expenses
|
(11,780 | ) | (30,473 | ) | ||||
Income taxes payable
|
20,413 | 20,936 | ||||||
Excess tax benefit on stock options exercised
|
(936 | ) | (1,872 | ) | ||||
Other liabilities
|
(835 | ) | 477 | |||||
Net
Cash Provided By Operating Activities
|
91,981 | 62,723 | ||||||
Cash
Flow From Investing Activities
|
||||||||
Proceeds
from sale of assets
|
- | 9,620 | ||||||
Additions
to property, plant and equipment
|
(21,281 | ) | (6,283 | ) | ||||
Proceeds
from note receivable
|
1,324 | 1,263 | ||||||
Contingent
acquisition payments
|
(241 | ) | (305 | ) | ||||
Change
in other long-term assets
|
(417 | ) | (111 | ) | ||||
Net
Cash (Used In) Provided by Investing Activities
|
(20,615 | ) | 4,184 | |||||
Cash
Flow From Financing Activities
|
||||||||
Long-term
debt repayment
|
(16,979 | ) | (8,453 | ) | ||||
Short-term
debt borrowings, net
|
31,434 | (100,000 | ) | |||||
Bank
overdrafts
|
561 | 293 | ||||||
Proceeds
from stock options exercised
|
2,071 | 2,761 | ||||||
Excess
tax benefit on stock options exercised
|
936 | 1,872 | ||||||
Payment
of cash dividends
|
(6,309 | ) | (5,307 | ) | ||||
Net
Cash Provided by (Used In) Financing Activities
|
11,714 | (108,834 | ) | |||||
Effect
of exchange rate changes on cash and cash equivalents
|
(838 | ) | 180 | |||||
Net
Change In Cash and Cash Equivalents
|
82,242 | (41,747 | ) | |||||
Cash
and Cash Equivalents at Beginning of Period
|
197,999 | 249,809 | ||||||
Cash
and Cash Equivalents at End of Period
|
$ | 280,241 | $ | 208,062 |
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(Dollars in thousands) |
2009
|
2008
|
||||||
Cash
paid during the year for:
|
||||||||
Interest
(net of amounts capitalized)
|
$ | 2,790 | $ | 9,270 | ||||
Income
taxes
|
$ | 5,349 | $ | 7,584 | ||||
Supplemental
disclosure of non-cash investing activities:
|
||||||||
Property,
plant and equipment expenditures included in Accounts
Payable
|
$ | 12,324 | $ | 932 |
Number
of Shares
|
Amounts
|
|||||||||||||||||||||||||||||||
Church
& Dwight Co., Inc. Stockholders' Equity
|
||||||||||||||||||||||||||||||||
Accumulated
|
||||||||||||||||||||||||||||||||
Additional
|
Other
|
|||||||||||||||||||||||||||||||
Common
|
Treasury
|
Common
|
Treasury
|
Paid-In
|
Retained
|
Comprehensive
|
Noncontrolling
|
|||||||||||||||||||||||||
(in
thousands)
|
Stock
|
Stock
|
Stock
|
Stock
|
Capital
|
Earnings
|
Income
(Loss)
|
Interest
|
||||||||||||||||||||||||
December
31, 2008
|
73,214 | (3,141 | ) | $ | 73,214 | $ | (37,304 | ) | $ | 252,129 | $ | 1,063,928 | $ | (20,454 | ) | $ | 192 | |||||||||||||||
Net
income
|
- | - | - | - | - | 62,569 | - | 7 | ||||||||||||||||||||||||
Translation
adjustments
|
- | - | - | - | - | - | (4,502 | ) | (3 | ) | ||||||||||||||||||||||
Derivative
agreements,
|
||||||||||||||||||||||||||||||||
net
of taxes of $485
|
- | - | - | - | - | - | 948 | - | ||||||||||||||||||||||||
Defined
Benefit Plans,
|
||||||||||||||||||||||||||||||||
net
of taxes of $9
|
- | - | - | - | - | - | (9 | ) | - | |||||||||||||||||||||||
Comprehensive
income
|
||||||||||||||||||||||||||||||||
Cash
dividends
|
- | - | - | - | - | (6,309 | ) | - | - | |||||||||||||||||||||||
Stock
purchases
|
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
Stock
based compensation
|
||||||||||||||||||||||||||||||||
expense
and stock option
|
||||||||||||||||||||||||||||||||
plan
transactions including
|
||||||||||||||||||||||||||||||||
related
income tax benefits of $1,293
|
- | 105 | - | 1,031 | 4,757 | - | - | - | ||||||||||||||||||||||||
Other
stock issuances
|
- | 10 | - | 105 | 178 | - | - | - | ||||||||||||||||||||||||
March
27, 2009
|
73,214 | (3,026 | ) | $ | 73,214 | $ | (36,168 | ) | $ | 257,064 | $ | 1,120,188 | $ | (24,017 | ) | $ | 196 |
1.
|
Basis
of Presentation
|
2.
|
Inventories
consist of the following:
|
March
27,
|
December
31,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Raw
materials and supplies
|
$ | 55,529 | $ | 52,850 | ||||
Work
in process
|
10,070 | 9,147 | ||||||
Finished
goods
|
134,283 | 136,896 | ||||||
Total
|
$ | 199,882 | $ | 198,893 |
3.
|
Property,
Plant and Equipment consist of the
following:
|
March
27,
|
December
31,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Land
|
$ | 25,579 | $ | 25,659 | ||||
Buildings
and improvements
|
143,531 | 143,590 | ||||||
Machinery
and equipment
|
420,628 | 421,012 | ||||||
Office
equipment and other assets
|
38,496 | 41,169 | ||||||
Software
|
36,692 | 36,729 | ||||||
Mineral
rights
|
1,158 | 1,146 | ||||||
Construction
in progress
|
89,976 | 60,949 | ||||||
756,060 | 730,254 | |||||||
Less
accumulated depreciation and amortization
|
357,095 | 345,735 | ||||||
Net
Property, Plant and Equipment
|
$ | 398,965 | $ | 384,519 |
4.
|
Earnings
Per Share (“EPS”)
|
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Weighted
average common shares outstanding - basic
|
70,234 | 66,343 | ||||||
Dilutive
effect of stock options
|
1,078 | 1,240 | ||||||
Dilutive
effect of convertible debt
|
- | 3,234 | ||||||
Weighted
average common shares outstanding - diluted
|
71,312 | 70,817 | ||||||
Antidilutive
stock options outstanding
|
712 | 490 |
5.
|
Stock-Based
Compensation
|
Weighted-
|
||||||||||||||||
Weighted-
|
Average
|
Aggregate
|
||||||||||||||
Average
|
Remaining
|
Intrinsic
|
||||||||||||||
Options
|
Exercise
|
Contractual
|
Value
|
|||||||||||||
(000)
|
Price
|
Term
|
$ |
(000)
|
||||||||||||
Outstanding
at January 1, 2009
|
4,258 | $ | 35.42 | |||||||||||||
Exercised
|
(105 | ) | 19.22 | |||||||||||||
Cancelled
|
(19 | ) | 47.98 | |||||||||||||
Outstanding
at March 27, 2009
|
4,134 | 35.75 | 6.1 | $ | 67,653 | |||||||||||
Exercisable
at March 27, 2009
|
2,097 | $ | 25.88 | 4.3 | $ | 53,583 |
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
millions)
|
2009
|
2008
|
||||||
Intrinsic
Value of Stock Options Exercised
|
$ | 3.3 | $ | 6.0 | ||||
Stock
Compensation Expense Related to Stock Option Awards
|
$ | 2.4 | $ | 2.3 |
6.
|
Fair
Value of Certain Instruments
|
March
27, 2009
|
||||||||||||||||
(In
thousands)
|
Carrying
Amount
|
Quoted
Prices in Active Markets for Identical Assets (Level
1)
|
Significant
Other Observable Inputs (Level 2)
|
Significant
Unobservable Inputs (Level 3)
|
||||||||||||
Assets
|
||||||||||||||||
Foreign
exchange contracts
|
$ | 523 | $ | - | $ | 523 | $ | - | ||||||||
Liabilities
|
||||||||||||||||
Interest
rate collars
|
$ | 6,953 | $ | - | $ | 6,953 | $ | - | ||||||||
Diesel
fuel contract
|
3,495 | - | 3,495 | - | ||||||||||||
$ | 10,448 | $ | - | $ | 10,448 | $ | - |
7.
|
Derivative
Instruments
|
Fair
Value at
|
Fair
Value at
|
|||||||||
(In
millions)
|
Balance
Sheet Location
|
March
27, 2009
|
December
31, 2008
|
|||||||
Derivatives
designated as hedging instruments under FAS No. 133
|
||||||||||
Asset
Derivatives
|
||||||||||
Foreign
exchange contracts
|
Accounts
receivable
|
$ | 0.5 | $ | 0.4 | |||||
Liability
Derivatives
|
||||||||||
Interest
rate collars
|
Accounts
payable and accrued expenses
|
$ | 1.8 | $ | - | |||||
Interest
rate collars
|
Other
long-term liabilities
|
5.1 | 7.9 | |||||||
Total
liabilities under FAS No. 133
|
$ | 6.9 | $ | 7.9 | ||||||
Derivatives
not designated as hedging instruments under FAS No. 133
|
||||||||||
Asset
Derivatives
|
||||||||||
Equity
derivatives
|
Accounts
receivable
|
$ | 0.3 | $ | - | |||||
Liability
Derivatives
|
||||||||||
Equity
derivatives
|
Accounts
payable and accrued expenses
|
$ | 0.7 | $ | 0.1 | |||||
Diesel
fuel contract
|
Accounts
payable and accrued expenses
|
4.4 | 4.5 | |||||||
Total
liabilities outside FAS No. 133
|
$ | 5.1 | $ | 4.6 | ||||||
Amount
of Gain (Loss) Recognized
in Income
|
Amount
of Gain (Loss) Recognized
in Income
|
|||||||||
Location
of Gain (Loss)
|
Three
Months Ended
|
Three
Months Ended
|
||||||||
(In
millions)
|
Recognized
in Income
|
March
27, 2009
|
March
28, 2008
|
|||||||
Derivatives
not designated as hedging instruments under FAS No. 133
|
||||||||||
Equity
derivatives
|
Selling,
general and administrative expenses
|
$ | (0.5 | ) | $ | (0.2 | ) | |||
Diesel
fuel contracts
|
Cost
of sales
|
(0.1 | ) | 1.9 | ||||||
Total
loss recognized in income
|
$ | (0.1 | ) | $ | 1.7 | |||||
Amount
of Gain Recognized
in OCI
|
Amount
of Gain Recognized
in OCI
|
|||||||||
from
Derivatives
|
from
Derivatives
|
|||||||||
Three
Months Ended
|
Three
Months Ended
|
|||||||||
(In
millions)
|
March
27, 2009
|
March
28, 2008
|
||||||||
Derivatives
in FAS No. 133 cash flow hedging relationship
|
||||||||||
Foreign
exchange contracts (net of taxes)
|
Other
comprehensive income
|
$ | 0.4 | $ | - | |||||
Interest
rate collars (net of taxes)
|
Other
comprehensive income
|
0.6 | 2.2 | |||||||
Total
gain recognized in OCI
|
$ | 1.0 | $ | 2.2 |
8.
|
Acquisitions
|
9.
|
Goodwill
and Other Intangible Assets
|
March
27, 2009
|
December
31, 2008
|
|||||||||||||||||||||||
Gross
|
Gross
|
|||||||||||||||||||||||
Carrying
|
Accumulated
|
Carrying
|
Accumulated
|
|||||||||||||||||||||
(In
thousands)
|
Amount
|
Amortization
|
Net
|
Amount
|
Amortization
|
Net
|
||||||||||||||||||
Amortizable intangible
assets:
|
||||||||||||||||||||||||
Tradenames
|
$ | 115,811 | $ | (40,555 | ) | $ | 75,256 | $ | 115,976 | $ | (38,648 | ) | $ | 77,328 | ||||||||||
Customer
Relationships
|
241,640 | (27,335 | ) | 214,305 | 241,640 | (24,045 | ) | 217,595 | ||||||||||||||||
Patents/Formulas
|
27,370 | (15,778 | ) | 11,592 | 27,220 | (14,977 | ) | 12,243 | ||||||||||||||||
Non
Compete Agreement
|
1,143 | (835 | ) | 308 | 1,143 | (807 | ) | 336 | ||||||||||||||||
Total
|
$ | 385,964 | $ | (84,503 | ) | $ | 301,461 | $ | 385,979 | $ | (78,477 | ) | $ | 307,502 | ||||||||||
Indefinite lived
intangible assets - Carrying value
|
||||||||||||||||||||||||
Tradenames
|
$ | 502,446 | $ | 502,671 |
(In
thousands)
|
Consumer Domestic |
Consumer International |
Specialty Products |
Total
|
||||||||||||
Balance
December 31, 2008
|
$ | 788,516 | $ | 36,486 | $ | 20,228 | $ | 845,230 | ||||||||
Goodwill
associated with the Orajel acquisition
|
13 | - | - | 13 | ||||||||||||
Additional
contingent consideration
|
169 | - | - | 169 | ||||||||||||
Balance
March 27, 2009
|
$ | 788,698 | $ | 36,486 | $ | 20,228 | $ | 845,412 |
10.
|
Short-Term
Borrowings and Long-Term Debt
|
March
27,
|
December
31,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Short-term
borrowings
|
||||||||
Securitization
of accounts receivable due in February 2010
|
$ | 30,000 | $ | 1,000 | ||||
Various
debt due to international banks
|
5,268 | 2,248 | ||||||
Total
short-term borrowings
|
$ | 35,268 | $ | 3,248 | ||||
Long-term
debt
|
||||||||
Term
Loan facility
|
$ | 585,913 | $ | 602,893 | ||||
Senior
subordinated notes (6%) due December 22, 2012
|
250,000 | 250,000 | ||||||
Total
long-term debt
|
835,913 | 852,893 | ||||||
Less:
current maturities
|
95,631 | 71,491 | ||||||
Net
long-term debt
|
$ | 740,282 | $ | 781,402 |
(In
thousands)
|
|||
Due
by March 2010
|
$ | 95,631 | |
Due
by March 2011
|
171,312 | ||
Due
by March 2012
|
187,862 | ||
Due
by December 2012
|
381,108 | ||
$ | 835,913 |
11.
|
Comprehensive
Income
|
Accumulated
|
||||||||||||||||
Foreign
|
Defined
|
Other
|
||||||||||||||
Currency
|
Benefit
|
Derivative
|
Comprehensive
|
|||||||||||||
(In thousands) |
Adjustments
|
Plans
|
Agreements
|
Income
(Loss)
|
||||||||||||
Balance
December 31, 2008
|
$ | (7,173 | ) | $ | (8,567 | ) | $ | (4,714 | ) | $ | (20,454 | ) | ||||
Comprehensive
income changes during
the three
months ended (net of tax of $ 494)
|
(4,502 | ) | (9 | ) | 948 | (3,563 | ) | |||||||||
Balance
March 27, 2009
|
$ | (11,675 | ) | $ | (8,576 | ) | $ | (3,766 | ) | $ | (24,017 | ) |
Three Months Ended | ||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Net
Income
|
$ | 62,569 | $ | 56,191 | ||||
Other
Comprehensive Income, Net of Tax:
|
||||||||
Foreign
Exchange Translation Adjustments
|
(4,502 | ) | (2,880 | ) | ||||
Derivative
Agreements
|
948 | (2,325 | ) | |||||
Defined
Benefit Plan Adjustments
|
(9 | ) | - | |||||
Comprehensive
Income
|
59,006 | 50,986 | ||||||
Comprehensive
Income attributable to the noncontrolling interest
|
4 | 2 | ||||||
Comprehensive
Income attributable to Church & Dwight Co., Inc.
|
$ | 59,010 | $ | 50,988 |
12.
|
Pension
and Postretirement Plans
|
Pension
Costs
|
||||||||
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Components
of Net Periodic Benefit Cost:
|
||||||||
Service cost
|
$ | 388 | $ | 723 | ||||
Interest cost
|
1,648 | 1,937 | ||||||
Expected return on plan assets
|
(1,483 | ) | (2,179 | ) | ||||
Amortization of prior service cost
|
- | 4 | ||||||
Recognized actuarial (gain) or loss
|
339 | (9 | ) | |||||
Net periodic benefit cost
|
$ | 892 | $ | 476 |
Postretirement
Costs
|
||||||||
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Components
of Net Periodic Benefit Cost:
|
||||||||
Service
cost
|
$ | 82 | $ | 187 | ||||
Interest
cost
|
315 | 367 | ||||||
Amortization
of prior service cost
|
15 | 11 | ||||||
Recognized
actuarial (gain) or loss
|
2 | - | ||||||
Net
periodic benefit cost
|
$ | 414 | $ | 565 |
13.
|
Commitments,
contingencies and guarantees
|
a.
|
In December 1981, the Company
formed a partnership with a supplier of raw materials which mines and
processes sodium-based mineral deposits. The Company purchases
the majority of its sodium-based raw material requirements from the
partnership. This agreement terminates upon two years’ written
notice by either company. The Company has an annual commitment
to purchase 240,000 tons of sodium-based raw materials at the prevailing
market price. The Company is not engaged in any other material
transactions with the partnership or the Company’s partner.
|
b.
|
Our
distribution of condoms under the TROJAN and other trademarks is regulated
by the U.S. Food and Drug Administration (“FDA”). Certain of our
condoms, and similar condoms sold by our competitors, contain the
spermicide nonoxynol-9 (“N-9”). Some interested groups have issued
reports that N-9 should not be used rectally or for multiple daily acts of
vaginal intercourse. In late 2008, the FDA issued final
labeling guidance for latex condoms but excluded N-9 lubricated condoms
from the guidance. While we await further FDA guidance on N-9
lubricated condoms, we believe that our present labeling for condoms with
N-9 is compliant with the overall objectives of the FDA’s guidance, and
that condoms with N-9 will remain a viable contraceptive choice for those
couples who wish to use them. However, we cannot predict the nature
of the labeling that ultimately will be required by the FDA. If the FDA or
state governments eventually promulgate rules that prohibit or restrict
the use of N-9 in condoms (such as new labeling requirements), we could
incur costs from obsolete products, packaging or raw materials, and sales
of condoms could decline, which, in turn, could decrease our operating
income.
|
c.
|
As
of March 27, 2009, the Company had commitments to acquire approximately
$112.1 million of raw material, packaging supplies and services from its
vendors at market prices. The packaging supplies are in either
a converted or non-converted status. These commitments enable
the Company to respond quickly to changes in customer orders or
requirements.
|
d.
|
The
Company has $3.3 million of outstanding letters of credit drawn on several
banks which guarantee payment for such things as insurance claims in the
event of the Company’s insolvency. In addition, the Company
guarantees the payment of rent on a leased facility in
Spain. The lease expires in November 2012 and the accumulated
monthly payments from March 27, 2009 through the remainder of the lease
term will amount to approximately $2.7 million. Approximately
two thirds of the rental space is subleased to a third
party.
|
e.
|
In
connection with the Company’s acquisition of Unilever’s oral care brands
in the United States and Canada in October 2003, the Company is required
to make additional performance-based payments of a minimum of $5.0 million
and a maximum of $12.0 million over the eight year period following the
acquisition. The Company made cash payments of $0.2 million,
and accrued a payment of $0.2 million in the first three months of
2009. The payment and accrual were accounted for as additional
purchase price. The Company has paid approximately $9.2
million, exclusive of the $0.2 million accrual, in additional
performance-based payments since the
acquisition.
|
f.
|
The
Company filed suit against Abbott Laboratories, Inc. (“Abbott”) in April
2005 claiming infringement of certain patents resulting from Abbott’s
manufacture and sale of its Fact Plus pregnancy diagnostic test
kits. Following a trial in February 2008, the jury found that the
Company’s patents were valid and willfully infringed by Abbott during the
period from April 1999 through September 2003 and awarded damages to the
Company in the amount of $14.6 million. On June 23, 2008, the District
Court issued an opinion finding that Abbott’s conduct had been willful and
doubled the damages awarded to the Company to $29.2 million. There remain
two post-trial motions filed by the Company with the District Court with
respect to prejudgment interest and attorney’s fees. Abbott has filed an
appeal of the verdict that has been deactivated pending a ruling on the
post-trial motions. In June 2007, Abbott filed a separate suit against the
Company claiming infringement of certain patents that are licensed to
Abbott, also in relation to pregnancy diagnostic test kits. The
Company is vigorously defending that
action.
|
g.
|
The
Company, in the ordinary course of its business, is the subject of, or a
party to, various pending or threatened legal actions. The
Company believes that any ultimate liability arising from these actions
will not have a material adverse effect on its financial position, results
of operations and cash flows.
|
14.
|
Related
Party Transactions
|
Armand
|
ArmaKleen
|
|||||||||||||||
Three
Months Ended
|
Three
Months Ended
|
|||||||||||||||
March
27,
|
March
28,
|
March
27,
|
March
28,
|
|||||||||||||
(In
millions)
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
Purchases
|
$ | 2.2 | $ | 2.8 | - | - | ||||||||||
Sales
|
- | - | $ | 1.0 | $ | 1.3 | ||||||||||
Outstanding
Accounts Receivable
|
$ | 0.3 | $ | 0.8 | $ | 0.9 | $ | 1.0 | ||||||||
Outstanding
Accounts Payable
|
$ | 0.3 | $ | 1.1 | - | - | ||||||||||
Administration
& Management Oversight
Services
(1)
|
$ | 0.4 | $ | 0.4 | $ | 0.7 | $ | 0.7 | ||||||||
(1)
Recorded as a reduction of selling, general and administrative
expenses.
|
15.
|
Sale
of Subsidiaries and Assets Held for
Sale
|
16.
|
Plant
Shutdown
|
17.
|
Segment
Information
|
Segment
|
Products
|
|
Consumer
Domestic
|
Household
and personal care products
|
|
Consumer
International
|
Primarily
personal care products
|
|
SPD
|
Specialty
chemical products
|
(In
thousands)
|
Consumer Domestic |
Consumer International |
SPD
|
Corporate
|
Total
|
|||||||||||||||
Net
Sales(1)
|
||||||||||||||||||||
First
Quarter 2009
|
$ | 438,090 | $ | 82,760 | $ | 60,017 | $ | - | $ | 580,867 | ||||||||||
First
Quarter 2008
|
382,744 | 99,694 | 70,429 | - | 552,867 | |||||||||||||||
Income
Before Income Taxes(2)
|
||||||||||||||||||||
First
Quarter 2009
|
$ | 79,934 | $ | 10,717 | $ | 6,136 | $ | 2,705 | $ | 99,492 | ||||||||||
First
Quarter 2008
|
67,831 | 7,252 | 9,941 | 2,380 | 87,404 |
(1)
|
Intersegment
sales from Consumer International to Consumer Domestic, which were $0.5
million and $2.1 million for the first quarter ended March 27, 2009 and
March 28, 2008, respectively, are not reflected in the
table.
|
(2)
|
In
determining Income Before Income Taxes, interest expense, investment
earnings, and other income (expense) were allocated among the segments
based upon each segment’s relative operating profit. The Corporate segment
income consists of equity in earnings of
affiliates.
|
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Household
Products
|
$ | 284,050 | $ | 242,827 | ||||
Personal
Care Products
|
154,040 | 139,917 | ||||||
Total
Consumer Domestic
|
438,090 | 382,744 | ||||||
Total
Consumer International
|
82,760 | 99,694 | ||||||
Total
SPD
|
60,017 | 70,429 | ||||||
Total
Consolidated Net Sales
|
$ | 580,867 | $ | 552,867 |
Segment
|
Products
|
|
Consumer
Domestic
|
Household
and personal care products
|
|
Consumer
International
|
Primarily
personal care products
|
|
SPD
|
Specialty
chemical products
|
Consumer
|
Consumer
|
|||||||||||||||||||
(In
thousands)
|
Domestic
|
International
|
SPD
|
Corporate
|
Total
|
|||||||||||||||
Net
Sales(1)
|
||||||||||||||||||||
First
Quarter 2009
|
$ | 438,090 | $ | 82,760 | $ | 60,017 | $ | - | $ | 580,867 | ||||||||||
First
Quarter 2008
|
382,744 | 99,694 | 70,429 | - | 552,867 | |||||||||||||||
Income
Before Income Taxes(2)
|
||||||||||||||||||||
First
Quarter 2009
|
$ | 79,934 | $ | 10,717 | $ | 6,136 | $ | 2,705 | $ | 99,492 | ||||||||||
First
Quarter 2008
|
67,831 | 7,252 | 9,941 | 2,380 | 87,404 |
(1)
|
Intersegment
sales from Consumer International to Consumer Domestic, which were $0.5
million and $2.1 million for the first quarter ended March 27, 2009 and
March 28, 2008, respectively, are not included in the
table.
|
(2)
|
In
determining Income Before Income Taxes, interest expense, investment
earnings, and other income (expense) were allocated among the segments
based upon each segment’s relative operating profit. The Corporate segment
income consists of equity in earnings of
affiliates.
|
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Household
Products
|
$ | 284,050 | $ | 242,827 | ||||
Personal
Care Products
|
154,040 | 139,917 | ||||||
Total
Consumer Domestic
|
438,090 | 382,744 | ||||||
Total
Consumer International
|
82,760 | 99,694 | ||||||
Total
SPD
|
60,017 | 70,429 | ||||||
Total
Consolidated Net Sales
|
$ | 580,867 | $ | 552,867 |
Three
Months Ended
|
||||||||
March
27,
|
March
28,
|
|||||||
(In
thousands)
|
2009
|
2008
|
||||||
Net
cash provided by operating activities
|
$ | 91,981 | $ | 62,723 | ||||
Net
cash (used in) provided by investing activities
|
$ | (20,615 | ) | $ | 4,184 | |||
Net
cash provided by (used in) financing activities
|
$ | 11,714 | $ | (108,834 | ) |
|
Accounts
receivable increased $8.0 million due to business
growth.
|
|
Inventories
increased $2.4 million primarily to support higher anticipated
sales.
|
|
Accounts
payable and other accrued expenses decreased $11.8 million primarily due
to the timing of incentive and profit sharing payments which were offset
partially by increased marketing expense
accruals.
|
|
Taxes
payable increased $20.4 million due to higher tax expense associated with
increased earnings and the timing of
payments.
|
a.
|
Evaluation
of Disclosure Controls and
Procedures
|
|
The
Company’s management, with the participation of the Company’s Chief
Executive Officer and Chief Financial Officer, evaluated the effectiveness
of the Company’s disclosure control and procedures at the end of the
period covered by this report. Based on that evaluation, the
Chief Executive Officer and Chief Financial Officer concluded that the
Company’s disclosure controls and procedures as of the end of the period
covered by this report are functioning effectively to provide reasonable
assurance that the information required to be disclosed by the Company in
reports filed under the Securities Exchange Act of 1934 is (i) recorded,
processed, summarized and reported within the time periods specified in
the SEC’s rules and forms, and (ii) accumulated and communicated to the
Company’s management, including the Chief Executive Officer and Chief
Financial Officer, as appropriate to allow timely decisions regarding the
disclosure.
|
b.
|
Change
in Internal Control over Financial
Reporting
|
|
No
change in the Company’s internal control over financial reporting occurred
during the Company’s most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the Company’s
internal control over financial
reporting.
|
Nominees
|
For
|
Withheld
|
||
T.
Rosie Albright
|
59,305,319
|
256,933
|
||
Ravichandra
K. Saligram
|
59,309,249
|
253,003
|
||
Robert
K. Shearer
|
59,106,758
|
455,494
|
For
|
Against
|
Abstain
|
||
58,638,124
|
897,259
|
26,869
|
•
|
(3.1)
|
Certificate
of Amendment of Restated Certificate of Incorporation dated June 4, 2008,
as filed with the Secretary of the State of Delaware on June 4,
2008.
|
•
|
(3.2)
|
Restated Certificate of Incorporation of the Corporation, as amended through June 4, 2008. |
(3.3)
|
By-laws
of the Company as amended, incorporated by reference to Exhibit 3.1 to the
Company’s current report on Form 8-K filed on February 3,
2009.
|
|
•
|
(11)
|
Computation
of earnings per share.
|
•
|
(31.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
•
|
(31.2)
|
Certification
of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
•
|
(32.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b)
under the Exchange Act and 18 U.S.C. Section 1350.
|
•
|
(32.2)
|
Certification
of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b)
under the Exchange Act and 18 U.S.C. Section 1350.
|
•
|
Indicates
documents filed herewith.
|
CHURCH & DWIGHT CO.,
INC.
|
|||
(REGISTRANT)
|
|||
DATE:
|
May
5, 2009
|
/s/
Matthew T. Farrell
|
|
MATTHEW
T. FARRELL
|
|||
CHIEF
FINANCIAL OFFICER
|
|||
DATE:
|
May
5, 2009
|
/s/
Steven J. Katz
|
|
STEVEN
J. KATZ
|
|||
VICE
PRESIDENT AND
|
|||
CONTROLLER
|
|||
(PRINCIPAL
ACCOUNTING OFFICER)
|
•
|
(3.1)
|
Certificate
of Amendment of Restated Certificate of Incorporation dated June 4, 2008,
as filed with the Secretary of the State of Delaware on June 4,
2008.
|
•
|
(3.2)
|
Restated Certificate of Incorporation of the Corporation, as amended through June 4, 2008. |
(3.3)
|
By-laws
of the Company as amended, incorporated by reference to Exhibit 3.1 to the
Company’s current report on Form 8-K filed on February 3,
2009.
|
|
•
|
(11)
|
Computation
of earnings per share.
|
•
|
(31.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
•
|
(31.2)
|
Certification
of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a)
under the Securities Exchange Act.
|
•
|
(32.1)
|
Certification
of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b)
under the Exchange Act and 18 U.S.C. Section 1350.
|
•
|
(32.2)
|
Certification
of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b)
under the Exchange Act and 18 U.S.C. Section 1350.
|
•
|
Indicates
documents filed herewith.
|